Clal Biotechnology Valuation
| CBI Stock | 46.40 1.60 3.57% |
At this time, the firm appears to be overvalued. Clal Biotechnology shows a prevailing Real Value of 35.74 per share. The current price of the firm is 46.4. Our model approximates the value of Clal Biotechnology from analyzing the firm fundamentals such as profit margin of (1.14) %, and Return On Equity of -0.45 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Clal Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of Clal Biotechnology is based on 3 months time horizon. Increasing Clal Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Clal Biotechnology Industries is useful when determining the fair value of the Clal stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Clal Biotechnology. Since Clal Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clal Stock. However, Clal Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 46.4 | Real 35.74 | Hype 46.4 | Naive 49.48 |
The real value of Clal Stock, also known as its intrinsic value, is the underlying worth of Clal Biotechnology Company, which is reflected in its stock price. It is based on Clal Biotechnology's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Clal Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Clal Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Clal Biotechnology Industries helps investors to forecast how Clal stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clal Biotechnology more accurately as focusing exclusively on Clal Biotechnology's fundamentals will not take into account other important factors: Clal Biotechnology Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Clal Biotechnology's current stock value. Our valuation model uses many indicators to compare Clal Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clal Biotechnology competition to find correlations between indicators driving Clal Biotechnology's intrinsic value. More Info.Clal Biotechnology Industries is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Clal Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Clal Biotechnology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clal Biotechnology's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Clal Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Clal Biotechnology and how it compares across the competition.
About Clal Biotechnology Valuation
The stock valuation mechanism determines the current worth of Clal Biotechnology Industries on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Clal Biotechnology Industries. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Clal Biotechnology based exclusively on its fundamental and basic technical indicators. By analyzing Clal Biotechnology's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Clal Biotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Clal Biotechnology. We calculate exposure to Clal Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Clal Biotechnology's related companies.Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. CLAL BIOTECHNOLOGY operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.
8 Steps to conduct Clal Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Clal Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Clal Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Clal Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Clal Biotechnology's revenue streams: Identify Clal Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Clal Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Clal Biotechnology's growth potential: Evaluate Clal Biotechnology's management, business model, and growth potential.
- Determine Clal Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Clal Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clal Biotechnology Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Clal Stock analysis
When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |